The 'Magnificent Seven' label is starting to mislead. The seven names that drove the 2023–2024 rally no longer trade as a group: some have extended the run on AI monetization, others have stalled on capex pressure or product missteps. Treating them as a single trade is now a mistake.
The split: monetizers vs. spenders
The cleanest way to bucket the group is by whether AI capex is showing up in the revenue line yet. The monetizers — names where AI is already a material revenue contributor — continue to expand multiples. The spenders — heavy capex with revenue still lagging — have seen multiples compress even as earnings beat. The dispersion within the group is the widest it's been in three years.
Concentration risk in the index
The top seven names are still roughly 30% of the S&P 500. That concentration cuts both ways: it juiced returns on the way up and will amplify drawdowns on any single-name disappointment. Passive index investors have implicit Mag 7 exposure whether they want it or not — active investors should size accordingly.
Where new leadership might emerge
When mega-cap leadership fades, history says the next leadership comes from the next tier down — high-quality mid-caps with secular growth and reasonable multiples. Watch the equal-weight S&P (RSP) vs. cap-weight (SPY) ratio: a sustained move higher in RSP/SPY signals broadening, which historically precedes mid-cap outperformance.
Trade implications
Don't buy or sell the Mag 7 as a basket. Treat each name on its own earnings trajectory and capex cycle. Use the earnings calendar to handicap each print individually — and consider pairing a long in a monetizer against a short in a spender within the same sector to harvest the dispersion without taking directional market risk.